Author:
Rao Wei,Xie Guohua,Zhang Yong,Wang Shujun,Wang Ying,Zhang Huizhen,Song Feifei,Zhang Renfeng,Yin Qinqin,Shen Lisong,Ge Hailiang
Publisher
Public Library of Science (PLoS)
Reference19 articles.
1. Tumor antigen targets and tumor immunotherapy;RA Mufson;Front Biosci,2006
2. Serological identification of human tumor antigens;U Sahin;Curr Opin Immunol,1997
3. Humoral immune responses against tumor-associated antigen OVA66 originally defined by serological analysis of recombinant cDNA expression libraries and its potentiality in cellular immunity;S Jin;Cancer Sci,2008
4. Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66;S Jin;Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi,2005
5. CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia. Proc Natl Acad Sci U.S.A;XF Yang,2001